Lopez JS, Im SA, Postel-Vinay S, Campone M, et al. Safety and efficacy of ceralasertib, an ATR kinase inhibitor, combined with olaparib: dose escalation in advanced solid tumours and dose expansion in advanced breast cancer. Br J Cancer 2026 Sep 30. doi: 10.1038/s41416-026-03601.
PMID: 42816529